A nanoemulsion-adjuvanted trivalent neuraminidase vaccine confers cross-protection against divergent influenza viruses

Jiaxin Bai, Shuang Li, Chen Zhao, Ting Yin, Diansong Li, Lirui Han, Yongbo Qiao, Yehong Wu · 2026

Read A nanoemulsion-adjuvanted trivalent neuraminidase vaccine confers cross-protection against divergent influenza viruses by Jiaxin Bai, Shuang Li, Chen Zhao, Ting Yin, Diansong Li, Lirui Han, Yongbo Qiao, Yehong Wu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13616710.txt.

Description

Jiaxin Bai and co-authors build a flu vaccine from a less-used viral surface protein, in a study from two thousand twenty-six. That protein changes less across strains than the usual target, which makes it a hopeful base for a broad vaccine. Proteins for three season strains were made in insect cells.

A nano-scale fat adjuvant boosted the vaccine in mouse tests. Antibody and T cell responses rose, and more immune cells made key signals. The three-part vaccine guarded mice against several flu strains, among them a bird flu strain. The team backs the multi-part design as a path toward a universal flu shot.

Catalog record

CREATORJiaxin Bai, Shuang Li, Chen Zhao, Ting Yin, Diansong Li, Lirui Han, Yongbo Qiao, Yehong Wu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13616710

Browse the full library · About the Tower of Babel